Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-20

Clinical Trial Update: Efficacy and Safety of Ascending Doses of Arpraziquantel in Children Infected With Opisthorchis Viverrini [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of ascending doses of arpraziquantel in children infected with Opisthorchis viverrini; recruitment not yet star…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Arpraziquantel (arpraziquantel)

Snippet

Sponsor: Jennifer Keiser | Conditions: Opisthorchis Viverrini | Phase 2 | Status: NOT_YET_RECRUITING